Skip to main content
ELVN logo

ELVN · Enliven Therapeutics, Inc.

Track ELVN — free
$56.81 -1.05 (-1.81%)
Market Cap
$4.24B
Shares
73.27M

Enliven Therapeutics, Inc. Earnings Call Transcripts

Quarterly earnings calls for Enliven Therapeutics, Inc. (ELVN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Conference
Investor event
2026-06-04
Enliven Therapeutics, Inc. (ELVN) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-27
Enliven Therapeutics, Inc. (ELVN) Q1 2026 Earnings Call
Diluted EPS
$-0.38
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-11-12
Enliven Therapeutics, Inc. (ELVN) Q3 2025 Earnings Call
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-06-13
Enliven Therapeutics, Inc. (ELVN) Q1 2025 Earnings Call
Diluted EPS
$-0.57
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-04-11
Enliven Therapeutics, Inc. (ELVN) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-03-15
Enliven Therapeutics, Inc. (ELVN) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Enliven Therapeutics, Inc. (ELVN) Q3 2021 Earnings Call
Diluted EPS
$-0.74
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Enliven Therapeutics, Inc. (ELVN) Q2 2021 Earnings Call
Diluted EPS
$-0.74
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Enliven Therapeutics, Inc. (ELVN) Q1 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-05
Enliven Therapeutics, Inc. (ELVN) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Enliven Therapeutics, Inc. (ELVN) Q3 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-14
Enliven Therapeutics, Inc. (ELVN) Q2 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–12 of 12 earnings calls
Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 196 filings 193 filers Visit website Investor relations